The last time we saw today's setup, one group of stocks more than doubled in four years and left U.S. stocks in the dust... It has nothing to do with China. And it might surprise you... European stocks are now dirt-cheap compared with their U.S. counterparts. Based on histo
Corcept Therapeutics (NASDAQ:CORT) is my favorite type of biotech company. It has an approved, marketed product with ramping sales, promising pipeline candidates, and is beginning to turn a profit. Both guidance by the company and analyst coverage suggest substantial growth in earnings and revenue. While not without the inherent risks of investing in a small/mid-cap biotech companies,....More>>>
U.S. stocks are only a few points away from new all-time highs… But not every part of the U.S. market has been thriving. Health care stocks recently fell 12% from their August highs to their pre-election lows… hitting an eight-month low in the process. Have they bottomed? Is it time to buy? Or is this the beginning of a major downtrend? Let's take a closer look....More>>>
As January and the new year settle in, many of us are wondering what 2017 will have in store. Even more interested are investors in Johnson Controls (NYSE:JCI), who are eager to see how the company performs after having completed its separation fromAdient and merger with Tyco. Fortunately, investors have the opportunity to gain some insight, as the company recently held its annual Analyst Day. Let’s....More>>>
Stop making it so complicated! A friend said to me yesterday, "I was thinking about selling stocks now – ahead of the election – and then buying them back afterward." Hey, that's fine, whatever makes him happy. But that's not an investing strategy… that's a speculation. It's not based on an understanding of the markets. Today, I want....More>>>
Sales Trends A Bit Soft, But Nothing To Worry About
I have been a bit disappointed by Nordstroms (NYSE:JWN) recent results. Not because it was a bad quarter per se, but because it broke the sequence of constant overperformance compared to other peers in the
It's been a bad month for Pegasystems (NASDAQ: PEGA), with investors running for the exits after a huge top-line miss in Q3. For an enterprise software company, there's probably nothing worse. Pegasystems sold off from all-time highs near $65 and now trades nearly 20% lower, in the low $50s.
I have previously written some articles where I have tracked Tesla's (NASDAQ:TSLA) construction and purchases of property, plant, and equipment (P,P & E), as well as Tesla's payments for them. The reason Tesla does not have to pay for all its equipment up front was explained in
Ever since the proposed acquisition of Rite Aid Corporation (NYSE:RAD) by Walgreens Boots Alliance Inc (NASDAQ:WBA) was restructured multiple times and eventually turned into an all-cash deal for a couple stores, RAD stock has been left for dead.